Resistance mechanisms include the aberrant expression of membrane transport proteins such as ATP-binding cassette transport proteins and P-glycoprotein, altered drug metabolic pathways, DNA repair, autophagy, hypoxic tumor microenvironments, enhanced stemness of tumor stem cells, mutations in epidermal growth factor receptor genes, and T cell depletion [35,36]. Here, EGFR is linked to neoplasm.